Now showing items 101-120 of 148

      Subject
      compulsory licensing, COVID-19, patent. [1]
      Controlled release, Diltiazem hydrochloride, Matrix system, Poloxamer-188, Polymer [1]
      Controlled release, Matrix system, Poloxamer-188, Polymer, Sildenafil citrate [1]
      controlled-release matrix system, differential scanning calorimetry, fourier transform infrared spectroscopy, hydroxypropyl methylcellulose, in vitro dissolution, poloxamer 407, scanning electron microscopy, stearyl alcohol, theophylline, thermogravimetric analysis, X-ray diffraction [1]
      controlled-release medications, differential scanning calorimetry, drug hydrous form, in vitro drug release, polymer grade, scanning electron microscopy, thermogravimetric analysis, X-ray diffraction [1]
      corticophobia, corticosteroids, COVID-19, knowledge, perception [1]
      Counterfeit, COVID-19, Falsified hand sanitizer, Regulation and compliance behaviours, Reliability analysis, Validation studies [1]
      Covalent organic framework nanoparticles (nCOF), Diabetes complications, Hemostasis disorders, Insulin delivery, Type 1 diabetes [1]
      Covid-19 pandemic, Vaccine preference, Vaccine skepticism, Willingness to pay, Willingness to vaccinate [1]
      COVID-19, Drug delivery, Immunotherapy, Nanoparticles, Pandemic, Vaccines [1]
      cyclodextrin, hair adhesion, hair keratin, minoxidil, thiomers [1]
      Cytotoxicity, Antioxidant, Phytochemicals, MD simulation, Molecular docking [1]
      dendrimers, intravesical delivery, liposomes, nanomaterial, targeted delivery [1]
      Development, future, medicines policy, Saudi Arabia [1]
      Diclofenac sodium tablet, First derivative, FTIR spectroscopy, Infrared quantitative analysis, Method development [1]
      dinaphthodiospyrol S, Diospyros kaki, Docking analysis, Extract, Xanthine oxidase activity [1]
      Direct-acting anticoagulants, DOAC, Factor Xa inhibitors, Medication errors, Pharmacists, Qualitative research [1]
      Disintegration, Dissolution spectrophotometric analysis, Lisinopril, Tablet splitting, Weight variation [1]
      disorganization of actin cytoskeletal network, hypomorphic variant, pip2 accumulation, plcb3, spondylometaphyseal dysplasia with corneal dystrophy (smdcd) [1]
      Drug discovery, Metal-stress; Microorganisms, Novel compounds, Plants [1]